Transferrin C2 variant does not confer a risk for Alzheimer's disease in Koreans

Neurosci Lett. 2001 Jul 27;308(1):45-8. doi: 10.1016/s0304-3940(01)01985-1.

Abstract

We analyzed the transferrin (TF) and apolipoprotein E (APOE) genotypes of 164 probable Alzheimer's disease (AD) patients and 239 cognitively normal elderly controls in Koreans. We failed to detect a significant difference in genotypic frequencies and allelic frequencies of the TF polymorphism between the AD group and control group (P>0.1 by Chi square test). The frequency of the TF C2 variant did not differ by the diagnosis when the APOE epsilon4-positive subjects and APOE epsilon4-negative subjects were analyzed separately (P>0.1 by Chi square test). The TF C2 variant did not influence the age-at-onset of AD independently or synergistically with the occurrence of the APOE epsilon4 allele (P>0.1 by ANOVA). The TF C2 variant did not confer a risk for AD in Koreans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / physiopathology
  • Apolipoproteins E / genetics*
  • Apolipoproteins E / metabolism
  • Chromosome Mapping
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease / genetics*
  • Genetic Testing
  • Genotype
  • Humans
  • Korea
  • Linkage Disequilibrium / genetics
  • Male
  • Polymorphism, Genetic / genetics*
  • Sex Factors
  • Transferrin / genetics*
  • Transferrin / metabolism

Substances

  • Apolipoproteins E
  • Transferrin